一个罕见的洛萨坦诱导的内脏血管瘤病例
Steven Rosas1, Austin Fowler2, Emily Stodgill1
1Mayo Clinic Health System, Menomonie, WI, USA.
Journal of primary care & community health
|November 15, 2023
概括
抗胰岛素II受体阻断剂 (ARB) 药物可以导致孤立的内脏性血管. 这一案例凸显了在患有无法解释的胃肠道症状的患者中考虑ARB诱导的血管的重要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 药物诱导的血管是药物影响氨酸-氨酸-阿尔多斯特系统 (RAAS) 的已知副作用.
- ангиотензинII受体阻断剂 (ARBs) 通常用于心血管疾病.
- 内脏血管,影响内部器官,是一个不太常见但严重的表现.
研究的目的:
- 报告与ARB使用相关的孤立内脏血管水病例.
- 讨论药物诱导的血管的病理生理学和临床表现.
- 提高有胃肠道症状的患者对ARB诱导的血管的认识.
主要方法:
- 案例报告的呈现方式.
- 关于药物诱导的血管和RAAS抑制剂的文献综述.
- 讨论ARB诱导的血管的拟议机制.
主要成果:
- 在接受ARB的患者中发现了一例孤立的内脏血管.
- 讨论涵盖了RAAS阻断诱导的血管的病理生理学,各种表现和拟议的机制.
结论:
- 在ARB或ACEI患者的差异诊断中应考虑内脏性血管炎,这些患者呈现出无法解释的胃肠道症状.
- 提高对ARB诱导的血管的认识对于及时诊断和管理至关重要.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
750
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
750
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
659
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
659
Antihypertensive Drugs: Direct Renin Inhibitors
648
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
648
Antihypertensive Drugs: Potassium-Sparing Diuretics
589
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
589
Heart Failure Drugs: Diuretics
400
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
400


